MiR-671 in ASC-derived exosomes targeted the transforming growth factor beta receptor 2 (TGFBR2) and suppressed the phosphorylation of SMAD2, enhancing cardiomyocyte viability and reducing myocardial fibrosis and inflammation [72]. Here, TGFBR2 is linked to Myocardial fibrosis.